Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96853139 | 9685313 | 9 | F | 2003 | 20160803 | 20131113 | 20160810 | EXP | US-009507513-1311USA004017 | MERCK | 0.00 | F | Y | 72.56000 | KG | 20160810 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96853139 | 9685313 | 1 | PS | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | 40180 | MG | 20560 | 70 | MG | TABLET | /wk | ||||
| 96853139 | 9685313 | 2 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | 40180 | MG | 20560 | TABLET | |||||||||
| 96853139 | 9685313 | 3 | SS | FOSAMAX PLUS D | ALENDRONATE SODIUMCHOLECALCIFEROL | 1 | Oral | U | 0 | TABLET | |||||||||
| 96853139 | 9685313 | 4 | SS | FOSAMAX PLUS D | ALENDRONATE SODIUMCHOLECALCIFEROL | 1 | U | 0 | TABLET | ||||||||||
| 96853139 | 9685313 | 5 | SS | ALENDRONATE SODIUM. | ALENDRONATE SODIUM | 1 | Oral | 70 MG, QW | U | U | 0 | 70 | MG | /wk | |||||
| 96853139 | 9685313 | 6 | C | VITAMINS (UNSPECIFIED) | VITAMINS | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 96853139 | 9685313 | 7 | C | calcium (unspecified) (+) vitamin D (unspecified) | CALCIUM CARBONATEVITAMIN D | 1 | Unknown | 1200 MG, UNK | U | U | 0 | 1200 | MG | ||||||
| 96853139 | 9685313 | 8 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | Unknown | 2000 IU, QD | U | U | 0 | 2000 | IU | QD | |||||
| 96853139 | 9685313 | 9 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Oral | 10 MG, PRN | U | U | 0 | 10 | MG | ||||||
| 96853139 | 9685313 | 10 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | 50MG 1/2 Q, QD | U | U | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96853139 | 9685313 | 1 | Osteopenia |
| 96853139 | 9685313 | 2 | Osteoporosis |
| 96853139 | 9685313 | 3 | Osteopenia |
| 96853139 | 9685313 | 4 | Osteoporosis |
| 96853139 | 9685313 | 9 | Back pain |
| 96853139 | 9685313 | 10 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96853139 | 9685313 | OT |
| 96853139 | 9685313 | HO |
| 96853139 | 9685313 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96853139 | 9685313 | Acute sinusitis | |
| 96853139 | 9685313 | Anaemia postoperative | |
| 96853139 | 9685313 | Anxiety | |
| 96853139 | 9685313 | Chest pain | |
| 96853139 | 9685313 | Cutaneous lupus erythematosus | |
| 96853139 | 9685313 | Ear congestion | |
| 96853139 | 9685313 | Femur fracture | |
| 96853139 | 9685313 | Foot fracture | |
| 96853139 | 9685313 | Intramedullary rod insertion | |
| 96853139 | 9685313 | Large intestine polyp | |
| 96853139 | 9685313 | Migraine | |
| 96853139 | 9685313 | Myalgia | |
| 96853139 | 9685313 | Nasal turbinate hypertrophy | |
| 96853139 | 9685313 | Pain in extremity | |
| 96853139 | 9685313 | Palpitations | |
| 96853139 | 9685313 | Papule | |
| 96853139 | 9685313 | Pyrexia | |
| 96853139 | 9685313 | Reflux laryngitis | |
| 96853139 | 9685313 | Stress | |
| 96853139 | 9685313 | Upper respiratory tract infection | |
| 96853139 | 9685313 | Vitamin D deficiency |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 96853139 | 9685313 | 1 | 20010821 | 20120813 | 0 | |
| 96853139 | 9685313 | 6 | 2001 | 2012 | 0 | |
| 96853139 | 9685313 | 7 | 2001 | 2012 | 0 | |
| 96853139 | 9685313 | 8 | 2001 | 2007 | 0 |